Kevin Virgil

CEO

Kevin Virgil is an entrepreneurial leader with a unique multidisciplinary background that spans public service, international finance and technology. As the CEO of Forever Labs, he is leading the company's transition from a biobank into a cutting-edge regenerative manufacturing platform.

Prior to Forever Labs, Kevin worked in corporate finance roles in the biotech and healthcare team at UBS, which was the highest revenue-producing healthcare group on Wall Street during his tenure. He is also the founder and CEO of Polysentry, a security software company that secured contracts with several federal agencies including a major ID/IQ contract with the U.S. Department of War.

Kevin is a West Point graduate who served with distinction in several Army units, to include the 75th Ranger Regiment. He also served in other roles abroad with the U.S. government, where he developed extensive government and business networks while stationed at the U.S. Embassy in Moscow and other locations.

Kevin likes to spend his off-duty time cheering on his two children at various sporting events and telling anyone within earshot about how his recent stem cell therapy eliminated the knee pain that he had, until recently, endured due to osteoarthritis.